Cameron Health Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 209
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $150M
Latest Deal Amount

Cameron Health General Information

Description

Developer and manufacturer of implantable defibrillators. The company offers subcutaneous implantable defibrillator (S-ICD) systems, which are battery powered electrical pulse generators and implanted in patients who are at risk for ventricular tachyarrhythmias; SQ-RX pulse generator, a component of the Cameron Health S-ICD system that is prescribed for patients when cardiac arrhythmia management is warranted; Q-TRAK subcutaneous electrode, a component of the Cameron Health S-ICD system, which is implanted subcutaneously with the distal portion positioned parallel to the left sternal border; Q-TECH programmer, which communicates wirelessly with the SQ-RX device to enable the adjustment of programmable settings and data collection; and Q-GUIDE subcutaneous electrode insertion tool.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Primary Office
  • 905 Calle Amanecer
  • Suite 300
  • San Clemente, CA 92673
  • United States
+1 (949) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cameron Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 15-Jun-2012 $150M 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series A2) 30-Jun-2011 0000 00000 Completed Generating Revenue
7. Later Stage VC (Series E) 12-Jun-2009 000.00 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series D) 09-May-2007 000.00 00000 00000 Completed Generating Revenue
5. Debt - General 05-Oct-2005 0000 000.00 Completed
4. Corporate 20-Feb-2004 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 20-Nov-2003 0000 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 02-Jun-2002 $31.5M $34.5M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 05-Aug-2001 $3M $3M 00.000 Completed Product Development
To view Cameron Health’s complete valuation and funding history, request access »

Cameron Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 00
Series C3 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series C2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 25,578,619 $0.000100 8% $1.24 $1.24 1x $1.24 19.55%
Series A 10,823,192 $0.000100 8% $0.35 $0.35 1x $0.35 8.27%
To view Cameron Health’s complete cap table history, request access »

Cameron Health Executive Team (4)

Name Title Board Seat Contact Info
Mitch Hill Chief Financial Officer
Gust Bardy MD Co-Founder
You’re viewing 2 of 4 executive team members. Get the full list »

Cameron Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cameron Health Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alloy Ventures Venture Capital Minority 000 0000 000000 0
Aperture Venture Partners Venture Capital Minority 000 0000 000000 0
BB Biotech Ventures Venture Capital Minority 000 0000 000000 0
CDIB BioScience Venture Management Venture Capital Minority 000 0000 000000 0
Delphi Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »